Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.6500
0.00 (0.00%)
Mar 25, 2026, 4:27 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 17.53 million as of March 25, 2026. Its market cap has increased by 179.47% in one year.
Market Cap
17.53M
Enterprise Value
16.96M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 17.53M, a decrease of -82.03%. That is a compound annual growth rate of -33.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 16.86M | -41.86% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 51.52M |
| hVIVO | 46.95M |
| Poolbeg Pharma | 30.14M |
| ImmuPharma | 25.64M |
| Arecor Therapeutics | 25.49M |
| Sareum Holdings | 21.40M |
| SkinBioTherapeutics | 16.20M |
| Fusion Antibodies | 14.38M |